Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | Cyclopamine | FIMM | pan-cancer | AAC | -0.064 | 0.7 |
mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | Bexarotene | FIMM | pan-cancer | AAC | -0.065 | 0.7 |
mRNA | QS11 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.7 |
mRNA | Sorafenib | FIMM | pan-cancer | AAC | -0.071 | 0.7 |
mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.021 | 0.7 |